- Home
- SENEA vs KRRO Comparison
SENEA vs KRRO Comparison
Compare SENEA & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- KRRO
- Stock Information
- Founded
- SENEA 1949
- KRRO 2014
- Country
- SENEA United States
- KRRO United States
- Employees
- SENEA N/A
- KRRO N/A
- Industry
- SENEA Packaged Foods
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- SENEA Consumer Staples
- KRRO Health Care
- Exchange
- SENEA Nasdaq
- KRRO Nasdaq
- Market Cap
- SENEA 629.3M
- KRRO 101.4M
- IPO Year
- SENEA N/A
- KRRO 2019
- Fundamental
- Price
- SENEA $103.73
- KRRO $12.77
- Analyst Decision
- SENEA
- KRRO Strong Buy
- Analyst Count
- SENEA 0
- KRRO 7
- Target Price
- SENEA N/A
- KRRO $85.67
- AVG Volume (30 Days)
- SENEA 124.1K
- KRRO 178.3K
- Earning Date
- SENEA 06-12-2025
- KRRO 08-12-2025
- Dividend Yield
- SENEA N/A
- KRRO N/A
- EPS Growth
- SENEA N/A
- KRRO N/A
- EPS
- SENEA 5.90
- KRRO N/A
- Revenue
- SENEA $1,578,887,000.00
- KRRO $4,821,000.00
- Revenue This Year
- SENEA N/A
- KRRO $65.08
- Revenue Next Year
- SENEA N/A
- KRRO N/A
- P/E Ratio
- SENEA $17.19
- KRRO N/A
- Revenue Growth
- SENEA 8.25
- KRRO N/A
- 52 Week Low
- SENEA $56.36
- KRRO $10.29
- 52 Week High
- SENEA $104.59
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- SENEA 74.12
- KRRO 47.09
- Support Level
- SENEA $98.53
- KRRO $11.52
- Resistance Level
- SENEA $96.48
- KRRO $12.86
- Average True Range (ATR)
- SENEA 3.42
- KRRO 0.97
- MACD
- SENEA 1.15
- KRRO 0.05
- Stochastic Oscillator
- SENEA 95.17
- KRRO 25.19
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.